BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1908639)

  • 1. Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries.
    McCarron JG; Quayle JM; Halpern W; Nelson MT
    Am J Physiol; 1991 Aug; 261(2 Pt 2):H287-91. PubMed ID: 1908639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilating effect of perivascularly applied potassium channel openers cromakalim and pinacidil in rat and cat pial arteries in situ.
    Wahl M; Parsons AA; Schilling L
    Cardiovasc Res; 1994 Dec; 28(12):1803-7. PubMed ID: 7867033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that acetylcholine-mediated hyperpolarization of the rat small mesenteric artery does not involve the K+ channel opened by cromakalim.
    McPherson GA; Angus JA
    Br J Pharmacol; 1991 May; 103(1):1184-90. PubMed ID: 1908733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle.
    Standen NB; Quayle JM; Davies NW; Brayden JE; Huang Y; Nelson MT
    Science; 1989 Jul; 245(4914):177-80. PubMed ID: 2501869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
    Masuzawa K; Matsuda T; Asano M
    Br J Pharmacol; 1990 May; 100(1):143-9. PubMed ID: 2115387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium channel openers dilate large epicardial coronary arteries in conscious dogs by an indirect, endothelium-dependent mechanism.
    la Rochelle CD; Richard V; Dubois-Randé JL; Roupie E; Giudicelli JF; Hittinger L; Berdeaux A
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1091-6. PubMed ID: 1469622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilatation of canine cerebral arteries by nicorandil, pinacidil and lemakalim.
    Zhang H; Stockbridge N; Weir B; Vollrath B; Cook D
    Gen Pharmacol; 1992 Mar; 23(2):197-201. PubMed ID: 1353469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
    Ksoll E; Parsons AA; Mackert JR; Schilling L; Wahl M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide.
    Gelband GH; McCullough JR
    Am J Physiol; 1993 May; 264(5 Pt 1):C1119-27. PubMed ID: 8498475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
    Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC
    Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers.
    Meisheri KD; Khan SA; Martin JL
    J Vasc Res; 1993; 30(1):2-12. PubMed ID: 8435468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Triggle CR; Li YQ; Wyse DG
    Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
    Iwamoto T; Nishimura N; Morita T; Sukamoto T
    J Pharm Pharmacol; 1993 Apr; 45(4):292-7. PubMed ID: 8098370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cromakalim, pinacidil and glibenclamide on cholinergic transmission in rat isolated atria.
    Fabiani ME; Story DF
    Pharmacol Res; 1995 Sep; 32(3):155-63. PubMed ID: 8745346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
    Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
    Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
    Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil.
    Rhim BY; Lee WS; Hong KW
    Jpn J Pharmacol; 1992; 58 Suppl 2():335P. PubMed ID: 1507584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.